Quinolinic acid inhibits DOI-induced head shakes in mice

Journal of Psychopharmacology

Volumn 13, Issue 3, 1999, Pages 284-286

  Himani Kariyawasam, S ^a   Handley, Sheila L ^a  

^a ASTON UNIVERSITY   (United Kingdom)

Author keywords

5 HT(2A) receptor; DOI; Head shakes; Kynurenine; Quinolinic acid

Indexed keywords

3 HYDROXYANTHRANILIC ACID; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; QUINOLINIC ACID; SEROTONIN 2A RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; HEAD MOVEMENT; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0345061671     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/026988119901300311     Document Type: Article

References (30)

1. Boulton C S, Handley S L (1973) Factors modifying the head-twitch response to 5-hydroxytryptophan. Psychopharmacologia (Berl) 31: 205-214
2. Brittain R T, Handley S L (1967) Temperature changes produced by the injection of catecholamines and 5-hydroxytryptamine into the cerebral ventricles of the conscious mouse. J Physiol 192: 805-813
3. Collier H O J, Hammond M D, Schneider C (1974) Biogenic amines and head twitches in mice during ethanol withdrawal. Br J Pharmacol 51: 130-131
4. Dursun S M, Handley S L (1992) Serotonin and Tourette's Syndrome may model human tics. Adv Biosci 85: 235-253
5. Dursun S M, Farrar G, Handley S L, Rickards H, Betts T, Corbett J A (1994) Elevated plasma kynurenine in Tourette Syndrome. Mol Chem Neuropathol 21: 55-59
6. Foster A C, Collins J F, Schwarcz R (1983) On the excitotoxic properties of quinolinic acid 2,3-piperidine dicarboxylic acids and structurally related compounds. Neuropharmacology 22: 1331-1342
7. Gaynor C M, Rickards E H G, Kariyawasam S H, Sidey F M, Corbett J A, Robertson M M, Handley S L (1997) Increased plasma kynurenine in Tourette syndrome may be due to induction of IDO. J Psychopharmacol 11 (Suppl 3): A23
8. Handley S L (1970) Study of the pharmacological actions of noradrenaline and related compounds injected into the brains of mice. PhD thesis, University of Aston, Birmingham
9. Handley S L, Miskin R C (1977) The interaction of some kynurenine pathway metabolites with 5-hydroxytryptophan and 5-hydroxytryptamine. Psychopharmacology 51: 305-309
10. Heaton J C P, Handley S L (1989) Comparison of DOI-induced scratching and head-twitch behaviours: differential action of 8-OH DPAT. Br J Pharmacol 98: 687P
11. Heyes M P (1993) Metabolism and neuropathological significance of quinolinic acid and kynurenic acid. Biochem Soc Trans 21: 83-89
12. 1A receptor binding affinity in mouse cerebral cortex. J Psychopharmacol 11 (Suppl 3): A22
13. 1C receptors mediate the 1,3 (chlorophenyl) piperazine-induced hypophagia. Br J Pharmacol 103: 2016-2020
14. 2C/2B receptor antagonist. Br J Pharmacol 111: 797-802
15. Kim J P, Choi D W (1987) Quinolinate neurotoxicity in cortical cell culture. Neurosciences 23: 423-432
16. Lapin I P (1978) Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice. J Neural Trans 42: 37-43
17. Lapin I P (1981) Kynurenines and seizures. Epilepsia 22: 257-265
18. Lapin I P (1989) Behavioural and convulsant effects of kynurenines. In Stone T W (eds), Quinolinic acid and kynurenines. CRC Press, Boca Raton, pp. 193-211
19. Lapin I P, Mutovkina L G, Ryzov I V, Mirzaev S (1996) Anxiogenic activity of quinolinic acid and kynurenine in the social interaction test in mice. J Psychopharmacol 10: 246-249
20. Luthman J, Vanerman E, Fredriksson G, Fornstedt-Wallin B (1996) Regulation of quinolinic acid in the normal rat brain by kynurenine pathway precursors. Adv Exp Med Biol 398: 229-239
21. McCreary A C, Handley S L (1995) Kynurenine potentiates the DOI head shake in mice. J Psychopharmacol 9: 69-70
22. Nakai M, Klarica M, Fage D, Carter C (1998) The pharmacology of native N-methyl-D-aspartate receptor subtypes: different receptors control the release of different striatal and spinal transmitters. Prog Neuropsychopharmacol Biol Psychiatry 22: 35-64
23. Pittaluga A, Vaccari D, Raiteri M (1997) The 'kynurenate test', a biochemical assay for putative cognition enhancers. J Pharmacol Exp Ther 283: 82-90
24. Reinhard Jr. J F, Erickson J B (1994) Quinolinic acid in neurological disease: opportunities for novel drug discovery. Adv Pharmacol 30: 85-126
25. Schwarcz R (1993) Metabolism and function of brain kynurenines. Biochem Soc Trans 21: 77-82
26. Stone T W (1993) Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45: 310-379
27. Stone T W, Perkins M N (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol 72: 411
28. Stone T W, Connick J H (1985) Quinolinic acid and other kynurenines in the central nervous system. Neurosciences 15: 597-617
29. 3H]norepinephrine from rat cortical slices. J Pharmacol Exp Ther 285: 105-109
30. Wolf H (1974) Studies on tryptophan metabolism in man. Scand J Clin Lab Invest 136 (Suppl.): 33